This is the first time the mechanism for PGC1β‐mediated LDHA expression in multiple myeloma has been identified, and this provides us with a novel antitumor strategy through targeting of the PGC1β/LDHA axis. The gene discussed is LDHA; the disease is plasma cell myeloma.